Skip to main content
ANAB
NASDAQ Life Sciences

Officer Dennis Mulroy Files Intent to Sell $576K in Shares, Continues Recent Sales Pattern

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$57.77
Mkt Cap
$1.681B
52W Low
$11.402
52W High
$72.36
52W Position info
407% above low
Off High info
20% below high
Rel. Volume info
0.6× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

An officer at AnaptysBio has filed to sell $576,000 in shares, adding to over $2.75 million in sales already executed this month, signaling continued insider distribution.


Key Events · Ownership and Investor Activity · ANAB

  • Officer Files Intent to Sell

    Dennis Mulroy, an officer, filed a Form 144 to sell 10,000 shares valued at approximately $576,000.

  • Recent Insider Sales

    This filing follows Mulroy's sale of 45,467 shares for gross proceeds of $2,752,623.04 in the past three months, with all sales occurring in May 2026.

  • Context of Corporate Actions

    These sales occur after the company completed its biopharma spin-off in April and announced a $100 million share repurchase program on May 12, 2026.


Analysis · ANAB · Life Sciences

Dennis Mulroy, an officer, has filed a Form 144 indicating intent to sell an additional $576,000 worth of shares. This follows recent sales totaling over $2.75 million by Mulroy in May, occurring after the company's spin-off and a new share repurchase program. This pattern of significant insider selling by an officer could be interpreted negatively, especially as the company recently completed a spin-off and announced a share repurchase program.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 29.6% of the 1609 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.57%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ANAB was trading at $57.77 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $11.40 to $72.36. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $50.85
Real-time Price: $50.26 info
Change: -$0.590 (-1%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:23 PM EDT
Filing Type: 10-KT
Importance Score:
8
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Sep 21, 2026, 4:15 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $55.99
Real-time Price: $50.26 info
Change: -$5.73 (-10%) info
Market Cap: $1.503B info
ANAB
Jun 29, 2026, 4:15 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $65.97
Real-time Price: $50.26 info
Change: -$15.71 (-24%) info
Market Cap: $1.503B info